PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine, Universidad de Sevilla. Hospital Universitario Virgen Macarena.\', \'Digestive Diseases, Hospital Universitario Virgen Macarena, EspaƱa.\', \'Digestive Diseases, Hospital Universitario Virgen Macarena.\', \'Pharmacology, Hospital Universitario Virgen Macarena.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.17235/reed.2021.8320/2021
?:hasPublicationType
?:journal
  • Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
is ?:pmid of
?:pmid
?:pmid
  • 34517718
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Switch to subcutaneous infliximab during the SARS-CoV-2 pandemic: preliminary results.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all